索拉非尼
癌症研究
肝细胞癌
药品
生物
谱系(遗传)
抗药性
医学
抗体
单克隆抗体
免疫学
抗体-药物偶联物
药理学
基因
遗传学
作者
Fan-En Kong,Guangmeng Li,Yunqiang Tang,Shaoyan Xi,Jane Ho Chun Loong,Meimei Li,Haolong Li,Wei Cheng,Wenjie Zhu,Jia-Qiang Mo,Yuanfeng Gong,Hui Tang,Yue Zhao,Yan Zhang,Stephanie Ma,Xin‐Yuan Guan,Ning‐Fang Ma,Maobin Xie,Ming Liu
标识
DOI:10.1126/scitranslmed.abb6282
摘要
CLDN6 is not only a marker of hepatocellular carcinoma but also a therapeutic target by promoting sorafenib resistance and lineage plasticity.
科研通智能强力驱动
Strongly Powered by AbleSci AI